Dual blocking of PI3K and mTOR signaling by DHW-221, a novel benzimidazole derivative, exerts antitumor activity in human non-small cell lung cancer
- Clin Transl Med. 2021 Sep;11(9):e514. doi: 10.1002/ctm2.514.
Affiliations
- 1. Department of Life Science and Biochemistry, Shenyang Pharmaceutical University, Shenyang, China.
- 2. Department of Pharmacy, General Hospital of Northern Theater Command, Shenyang, China.
- 3. Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, China.
PMID: 34586727
DOI: 10.1002/ctm2.514
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: PI3K; mTOR; Akt; Apoptosis; Paraptosis; p38 MAPK; Mitochondrial Metabolism; P-glycoprotein; CDK; MMP; HIF/HIF Prolyl-Hydroxylase; VEGFRResearch Areas: Cancer